Ilkay KALKAN
(Sağlık Bilimleri Üniversitesi, Atatürk Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Alerji ve Klinik İmmünoloji Anabilim Dalı, Ankara, Türkiye)
Gözde BUHARI
(Sağlık Bilimleri Üniversitesi, Atatürk Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Alerji ve Klinik İmmünoloji Anabilim Dalı, Ankara, Türkiye)
Hale ATEŞ
(Sağlık Bilimleri Üniversitesi, Atatürk Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Alerji ve Klinik İmmünoloji Anabilim Dalı, Ankara, Türkiye)
Buket AKDOĞAN
(Sağlık Bilimleri Üniversitesi, Atatürk Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Alerji ve Klinik İmmünoloji Anabilim Dalı, Ankara, Türkiye)
Özlem ÖZDEDEOĞLU
(Sağlık Bilimleri Üniversitesi, Atatürk Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Alerji ve Klinik İmmünoloji Anabilim Dalı, Ankara, Türkiye)
KURTULUŞ AKSU
(Sağlık Bilimleri Üniversitesi, Atatürk Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Alerji ve Klinik İmmünoloji Anabilim Dalı, Ankara, Türkiye)
Ferda Öner ERKEKOL
(Ankara Yıldırım Beyazıt Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, İmmünoloji ve Allerji Anabilim Dalı, Ankara, Türkiye)
Yıl: 2021Cilt: 19Sayı: 2ISSN: 1308-9234Sayfa Aralığı: 100 - 109İngilizce

43 0
Can Fractional Exhaled Nitric Oxide with Blood Eosinophil Count Have a Place in the Diagnostic Algorithm for Asthma?
Objective: Guidelines suggest using bronchial provocation testing (BPT), which is hard to attain, in patients with asthma-like symptoms presenting with nondiagnostic spirometric tests. To eliminate the risk of over/underdiagnosing asthma, we aimed to evaluate the predictive value of not only fractional exhaled nitric oxide (FeNO) but also other easily accessible clinical indices for ruling in/out asthma. Materials and Methods: This retrospective study included adults presenting to our clinic with respiratory symptoms suggestive of asthma but with normal spirometric values and negative reversibility test, who underwent FeNO and methacholine BPT (MchBPT). Medical records were used to obtain descriptive characteristics, clinical history, allergy screening, eosinophils in peripheral blood, and spirometry. Results: Among 51 patients, 19 were diagnosed with asthma. Body mass index and blood eosinophils were significantly higher in patients with positive MchBPT (p=0.042 and p=0.037, respectively). No significant difference was found in other indices, including FeNO (p=0.293). Receiver operating characteristic curve analysis revealed the best diagnostic cutoff level for FeNO as 14 ppb and blood eosinophil as 150/μl for the prediction of positive MchBPT (with 63.16%-62.5% and 80%-61% sensitivity-specificity, respectively). These two indices were the only independent predictors of positive BHR, and the model of FeNO>14ppb combined with eos>150/μl showed 100% specificity with a 100% negative predictive value. Conclusion: Our results suggest using the combination of FeNO with blood eosinophil count as a rule-out test, adding a new step in the algorithmic diagnosis of asthma. This might avoid an unnecessary BPT procedure, reduce the risk of over/under-diagnosis of asthma, and hasten the correct diagnosis.
DergiAraştırma MakalesiErişime Açık
  • 1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. 2020. https://ginasthma.org/gina-reports/
  • 2. Schneider A, Gindner L, Tilemann L, Schermer T, Dinant GJ, Meyer FJ, et al. Diagnostic accuracy of spirometry in primary care. BMC Pulm Med 2009;9:31.
  • 3. Nair P, Martin JG, Cockcroft DC, Dolovich M, Lemiere C, Boulet LP, et al. Airway hyperresponsiveness in asthma: Measurement and clinical relevance. J Allergy Clin Immunol Pract 2017;5(3):649-59.e2.
  • 4. Bao W, Zhang X, Lv C, Bao L, Yin J, Huang Z, et al. The value of fractional exhaled nitric oxide and forced mid-expiratory flow as predictive markers of bronchial hyperresponsiveness in adults with chronic cough. J Allergy Clin Immunol Prac 2018;6(4):1313-20.
  • 5. Karrasch S, Linde K, Rücker G, Sommer H, Karsch-Völk M, Kleijnen J, et al. Accuracy of FENO for diagnosing asthma: A systematic review. Thorax 2017;72(2):109-16.
  • 6. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993;6(9):1368-70.
  • 7. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998;53(2):91-5.
  • 8. Miller A, Enright PL. PFT interpretive strategies: American Thoracic Society/ European Respiratory Society 2005 guideline gaps. Respir Care 2012;57(1):127-33; discussion 33-35.
  • 9. American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171(8):912-30.
  • 10. Coates AL, Wanger J, Cockcroft DW, Culver BH, Diamant Z, Gauvreau G, et al. ERS technical standard on bronchial challenge testing: General considerations and performance of methacholine challenge tests. Eur Respir J 2017;49(5):1601526.
  • 11. O’Connor G, Sparrow D, Taylor D, Segal M, Weiss S. Analysis of dose-response curves to methacholine. An approach suitable for population studies. Am Rev Respir Dis 1987;136(6):1412-7.
  • 12. Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr 2019;7:246.
  • 13. Aaron SD, Vandemheen KL, FitzGerald JM, Ainslie M, Gupta S, Lemière C, et al. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA 2017;317(3):269-79.
  • 14. Shaw D, Green R, Berry M, Mellor S, Hargadon B, Shelley M, et al. A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma. Prim Care Respir J 2012;21(3):283-7.
  • 15. Kavanagh J, Jackson DJ, Kent BD. Over- and under-diagnosis in asthma. Breathe (Sheff) 2019;15(1):e20-e7.
  • 16. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma (BTS/SIGN Asthma Guideline). 2016 https://www.brit-thoracic.org.uk/quality-improvement/guidelines/asthma/.
  • 17. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988;137(1):62-9.
  • 18. Polosa R, Renaud L, Cacciola R, Prosperini G, Crimi N, Djukanovic R. Sputum eosinophilia is more closely associated with airway responsiveness to bradykinin than methacholine in asthma. Eur Respir J 1998;12(3):551-6.
  • 19. Nickels AS, Lim KG. Evaluation of exhaled nitric oxide’s ability to predict methacholine challenge in adults with nonobstructive spirometry. Ann Allergy Asthma Immunol 2016;117(4):365-9.e1.
  • 20. Choi SH, Kim DK, Yu J, Yoo Y, Koh YY. Bronchial responsiveness to methacholine and adenosine 5’-monophosphate in young children with asthma: Their relationship with blood eosinophils and serum eosinophil cationic protein. Allergy 2007;62(10):1119-24.
  • 21. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184(5):602-15.
  • 22. National Institute for Health and Care Excellence (NICE) Asthma: diagnosis, monitoring and chronic asthma management. NG80. 2017. https:// www.nice.org.uk/guidance/ng80.
  • 23. Wang Z, Pianosi PT, Keogh KA, Zaiem F, Alsawas M, Alahdab F, et al. The Diagnostic Accuracy of Fractional Exhaled Nitric Oxide Testing in Asthma: A Systematic Review and Meta-analyses. Mayo Clin Proc 2018;93(2):191-8.
  • 24. Cloutier MM, Baptist AP, Blake KV, Brooks EG, Bryant-Stephens T, DiMango E, et al. 2020 Focused updates to the asthma management guidelines: A report from the national asthma education and prevention program coordinating committee expert panel working group. J Allergy Clin Immunol 2020;146(6):1217-70.
  • 25. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360(10):973-84.
  • 26. Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011;365(12):1088-98.
  • 27. Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 2013;368(26):2455-66.
  • 28. Malinovschi A, Fonseca JA, Jacinto T, Alving K, Janson C. Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects. J Allergy Clin Immunol 2013;132(4):821-7.e1-5.
  • 29. Malinovschi A, Janson C, Borres M, Alving K. Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity. J Allergy Clin Immunol 2016;138(5):1301-8.e2.
  • 30. Price DB, Bosnic-Anticevich S, Pavord ID, Roche N, Halpin DMG, Bjermer L, et al. Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations. Clin Transl Allergy 2019;9:41.
  • 31. Çolak Y, Afzal S, Nordestgaard BG, Marott JL, Lange P. Combined value of exhaled nitric oxide and blood eosinophils in chronic airway disease: The Copenhagen General Population Study. Eur Respir J 2018;52(2):1800616.
  • 32. Cockcroft DW, Davis BE. Histamine and methacholine challenge cut points. Ann Allergy Asthma Immunol 2010;104:450-1.
  • 33. Cockcroft DW, Murdock KY, Berscheid BA, Gore BP. Sensitivity and specificity of histamine PC20 determination in a random selection of young college students. J Allergy Clin Immunol 1992;89(1 Pt 1):23-30.
  • 34. Guo FH, Uetani K, Haque SJ, Williams BR, Dweik RA, Thunnissen FB, et al. Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J Clin Invest 1997;100(4):829-38.
  • 35. Modena BD, Tedrow JR, Milosevic J, Bleecker ER, Meyers DA, Wu W, et al. Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways. Am J Respir Crit Care Med 2014;190(12):1363-72.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.